Heron Therapeutics, Inc. (HRTX)
0.3228
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
0.3181
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Shareholders Equity (Quarterly) : 6.908M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.908M |
| March 31, 2026 | 9.137M |
| December 31, 2025 | 14.33M |
| September 30, 2025 | 14.88M |
| June 30, 2025 | -27.26M |
| March 31, 2025 | -28.45M |
| December 31, 2024 | -33.65M |
| September 30, 2024 | -40.00M |
| June 30, 2024 | -37.94M |
| March 31, 2024 | -33.77M |
| December 31, 2023 | -33.97M |
| September 30, 2023 | -27.79M |
| June 30, 2023 | -39.28M |
| March 31, 2023 | -11.43M |
| December 31, 2022 | 13.57M |
| September 30, 2022 | 22.45M |
| June 30, 2022 | -21.74M |
| March 31, 2022 | 23.96M |
| December 31, 2021 | 77.57M |
| September 30, 2021 | 118.84M |
| June 30, 2021 | 160.11M |
| March 31, 2021 | 196.22M |
| December 31, 2020 | 236.49M |
| September 30, 2020 | 277.15M |
| June 30, 2020 | 324.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 365.47M |
| December 31, 2019 | 403.84M |
| September 30, 2019 | 285.44M |
| June 30, 2019 | 305.36M |
| March 31, 2019 | 331.81M |
| December 31, 2018 | 370.16M |
| September 30, 2018 | 406.81M |
| June 30, 2018 | 431.89M |
| March 31, 2018 | 92.21M |
| December 31, 2017 | 131.14M |
| September 30, 2017 | 40.05M |
| June 30, 2017 | 69.08M |
| March 31, 2017 | 102.16M |
| December 31, 2016 | -21.25M |
| September 30, 2016 | 17.88M |
| June 30, 2016 | 57.84M |
| March 31, 2016 | 92.68M |
| December 31, 2015 | 118.11M |
| September 30, 2015 | 141.70M |
| June 30, 2015 | 159.87M |
| March 31, 2015 | 48.00M |
| December 31, 2014 | 63.06M |
| September 30, 2014 | 81.01M |
| June 30, 2014 | 97.85M |
| March 31, 2014 | 55.41M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 1.341B |
| Tonix Pharmaceuticals Holding Corp. | 222.28M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.26M |
| Total Liabilities (Quarterly) | 245.35M |
| Debt to Equity Ratio | 21.48 |
| Current Ratio | 2.494 |
| Net Debt Paydown Yield | 7.15% |